Qube Research & Technologies Ltd Takes Position in Agiliti, Inc. (NYSE:AGTI)

Qube Research & Technologies Ltd purchased a new stake in shares of Agiliti, Inc. (NYSE:AGTIGet Rating) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 18,194 shares of the company’s stock, valued at approximately $421,000.

A number of other hedge funds have also recently made changes to their positions in AGTI. Morgan Stanley bought a new position in Agiliti during the second quarter valued at about $156,000. Royal Bank of Canada bought a new position in Agiliti during the second quarter valued at about $47,000. Wells Fargo & Company MN bought a new position in Agiliti during the second quarter valued at about $1,432,000. Strs Ohio boosted its stake in Agiliti by 88.5% during the third quarter. Strs Ohio now owns 9,800 shares of the company’s stock valued at $186,000 after buying an additional 4,600 shares in the last quarter. Finally, BlackRock Inc. boosted its stake in Agiliti by 5.3% during the third quarter. BlackRock Inc. now owns 2,998,163 shares of the company’s stock valued at $57,086,000 after buying an additional 149,986 shares in the last quarter. 99.81% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts recently weighed in on the company. Raymond James decreased their price target on Agiliti from $30.00 to $25.00 and set an “outperform” rating for the company in a research report on Friday, March 11th. Citigroup decreased their price target on Agiliti from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Wednesday, March 9th. Morgan Stanley decreased their price objective on Agiliti from $30.00 to $24.00 and set an “overweight” rating for the company in a research report on Thursday, March 10th. BMO Capital Markets raised their price objective on Agiliti from $22.00 to $28.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 6th. Finally, The Goldman Sachs Group decreased their price objective on Agiliti from $32.00 to $28.00 and set a “buy” rating for the company in a research report on Friday, March 11th. One research analyst has rated the stock with a sell rating, one has given a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, Agiliti presently has a consensus rating of “Buy” and a consensus target price of $23.00.

AGTI opened at $20.16 on Friday. The business has a 50-day moving average of $19.66 and a 200-day moving average of $20.59. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.72 and a quick ratio of 1.45. Agiliti, Inc. has a fifty-two week low of $13.56 and a fifty-two week high of $26.36. The company has a market capitalization of $2.64 billion and a PE ratio of 106.11.

Agiliti (NYSE:AGTIGet Rating) last issued its quarterly earnings data on Tuesday, March 8th. The company reported $0.25 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.09 by $0.16. Agiliti had a return on equity of 15.02% and a net margin of 2.31%. On average, equities research analysts expect that Agiliti, Inc. will post 0.85 earnings per share for the current fiscal year.

In related news, CEO Thomas J. Leonard sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 10th. The stock was sold at an average price of $18.04, for a total value of $541,200.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO James B. Pekarek sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 2nd. The shares were sold at an average price of $18.49, for a total value of $369,800.00. The disclosure for this sale can be found here. Insiders sold a total of 145,127 shares of company stock worth $2,634,379 over the last three months. 4.16% of the stock is owned by company insiders.

Agiliti Profile (Get Rating)

Agiliti, Inc provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity.

Further Reading

Want to see what other hedge funds are holding AGTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agiliti, Inc. (NYSE:AGTIGet Rating).

Institutional Ownership by Quarter for Agiliti (NYSE:AGTI)

Receive News & Ratings for Agiliti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agiliti and related companies with MarketBeat.com's FREE daily email newsletter.